Cancer Research Cancer Research Funding Available Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
[Cancer Research 59, 525-528, February 1, 1999]
© 1999 American Association for Cancer Research
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Speirs, V.
Right arrow Articles by Atkin, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Speirs, V.
Right arrow Articles by Atkin, S. L.
[Cancer Research 59, 525-528, February 1, 1999]
© 1999 American Association for Cancer Research

Advances in Brief

Coexpression of Estrogen Receptor {alpha} and ß

Poor Prognostic Factors in Human Breast Cancer?1

Valerie Speirs2, Alicia T. Parkes, Michael J. Kerin, David S. Walton, Peter J. Carleton, John N. Fox and Stephen L. Atkin

Departments of Medicine [V. S., A. T. P., D. S. W., S. L. A.] and Surgery [M. J. K., P. J. C., J. N. F.], University of Hull, Hull HU6 7RX, United Kingdom

The cloning of a second estrogen receptor (ER), ERß, has prompted a reevaluation of the role of ERs in breast cancer. The aim of this study was to determine the expression of both ER isoforms in normal (n = 23) and malignant (n = 60) human breast tissue by reverse transcription-PCR and correlate this information with known prognostic factors including tumor grade and node status. In normal breast tissue, expression of ERß predominated, with 22% of samples exclusively expressing ERß; this was not observed in any of the breast tumor samples investigated. Most breast tumors expressed ER{alpha}, either alone or in combination with ERß. Interestingly, those tumors that coexpressed ER{alpha} and ERß were node positive (P = 0.02; Fisher’s exact test) and tended to be of higher grade. Because antiestrogens are agonists when signaling through the AP1 element, overexpression of ERß in tumors expressing both ER subtypes may explain the failure of antiestrogen therapy in some breast cancer patients. Thus, ERß may be a useful prognostic factor in patients with breast cancer.




This article has been cited by other articles:


Home page
 J Mol EndocrinolHome page
S. E Ghayad, J. A Vendrell, I. Bieche, F. Spyratos, C. Dumontet, I. Treilleux, R. Lidereau, and P. A Cohen
Identification of TACC1, NOV, and PTTG1 as new candidate genes associated with endocrine therapy resistance in breast cancer
J. Mol. Endocrinol., February 1, 2009; 42(2): 87 - 103.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. M. Shaaban, A. R. Green, S. Karthik, Y. Alizadeh, T. A. Hughes, L. Harkins, I. O. Ellis, J. F. Robertson, E. C. Paish, P. T.K. Saunders, et al.
Nuclear and Cytoplasmic Expression of ER{beta}1, ER{beta}2, and ER{beta}5 Identifies Distinct Prognostic Outcome for Breast Cancer Patients
Clin. Cancer Res., August 15, 2008; 14(16): 5228 - 5235.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
N. Honma, R. Horii, T. Iwase, S. Saji, M. Younes, K. Takubo, M. Matsuura, Y. Ito, F. Akiyama, and G. Sakamoto
Clinical Importance of Estrogen Receptor-{beta} Evaluation in Breast Cancer Patients Treated With Adjuvant Tamoxifen Therapy
J. Clin. Oncol., August 1, 2008; 26(22): 3727 - 3734.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
M. A. Cho, M. K. Lee, K.-H. Nam, W. Y. Chung, C. S. Park, J. H. Lee, T. Noh, W. I. Yang, Y. Rhee, S.-K. Lim, et al.
Expression and role of estrogen receptor {alpha} and {beta} in medullary thyroid carcinoma: different roles in cancer growth and apoptosis
J. Endocrinol., November 1, 2007; 195(2): 255 - 263.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
H. Sugiura, T. Toyama, Y. Hara, Z. Zhang, S. Kobayashi, Y. Fujii, H. Iwase, and H. Yamashita
Expression of Estrogen Receptor Wild-type and its Variant ER cx/ 2 is Correlated with Better Prognosis in Breast Cancer
Jpn. J. Clin. Oncol., November 1, 2007; 37(11): 820 - 828.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Pandini, M. Genua, F. Frasca, S. Squatrito, R. Vigneri, and A. Belfiore
17{beta}-Estradiol Up-regulates the Insulin-like Growth Factor Receptor through a Nongenotropic Pathway in Prostate Cancer Cells
Cancer Res., September 15, 2007; 67(18): 8932 - 8941.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. K. Gruvberger-Saal, P.-O. Bendahl, L. H. Saal, M. Laakso, C. Hegardt, P. Eden, C. Peterson, P. Malmstrom, J. Isola, A. Borg, et al.
Estrogen Receptor {beta} Expression Is Associated with Tamoxifen Response in ER{alpha}-Negative Breast Carcinoma
Clin. Cancer Res., April 1, 2007; 13(7): 1987 - 1994.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
M. H. Herynk, A. R. Beyer, Y. Cui, H. Weiss, E. Anderson, T. P. Green, and S. A.W. Fuqua
Cooperative action of tamoxifen and c-Src inhibition in preventing the growth of estrogen receptor-positive human breast cancer cells
Mol. Cancer Ther., December 1, 2006; 5(12): 3023 - 3031.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
B. Moy and P. E. Goss
Estrogen Receptor Pathway: Resistance to Endocrine Therapy and New Therapeutic Approaches.
Clin. Cancer Res., August 15, 2006; 12(16): 4790 - 4793.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
A Rody, U Holtrich, C Solbach, K Kourtis, G von Minckwitz, K Engels, S Kissler, R Gatje, T Karn, and M Kaufmann
Methylation of estrogen receptor {beta} promoter correlates with loss of ER-{beta} expression in mammary carcinoma and is an early indication marker in premalignant lesions
Endocr. Relat. Cancer, December 1, 2005; 12(4): 903 - 916.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
J. H. Kim, M. H. Lee, B. J. Kim, J. H. Kim, S. J. Han, H. Y. Kim, and M. R Stallcup
Role of aspartate 351 in transactivation and active conformation of estrogen receptor {alpha}
J. Mol. Endocrinol., December 1, 2005; 35(3): 449 - 464.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
I. Poola, S. A.W. Fuqua, R. L. De Witty, J. Abraham, J. J. Marshallack, and A. Liu
Estrogen Receptor {alpha}-Negative Breast Cancer Tissues Express Significant Levels of Estrogen-Independent Transcription Factors, ER{beta}1 and ER{beta}5: Potential Molecular Targets for Chemoprevention
Clin. Cancer Res., October 15, 2005; 11(20): 7579 - 7585.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
C. Qiu, L. Shan, M. Yu, and E. G. Snyderwine
Steroid hormone receptor expression and proliferation in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
Carcinogenesis, April 1, 2005; 26(4): 763 - 769.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
V. Cappelletti, L. Celio, E. Bajetta, A. Allevi, R. Longarini, P. Miodini, R. Villa, A. Fabbri, L. Mariani, R. Giovanazzi, et al.
Prospective evaluation of estrogen receptor-{beta} in predicting response to neoadjuvant antiestrogen therapy in elderly breast cancer patients
Endocr. Relat. Cancer, December 1, 2004; 11(4): 761 - 770.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
M P A Davies, P A O'Neill, H Innes, D R Sibson, W Prime, C Holcombe, and C S Foster
Correlation of mRNA for oestrogen receptor beta splice variants ER{beta}1, ER{beta}2/ER{beta}cx and ER{beta}5 with outcome in endocrine-treated breast cancer
J. Mol. Endocrinol., December 1, 2004; 33(3): 773 - 782.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
M. H. Herynk and S. A. W. Fuqua
Estrogen Receptor Mutations in Human Disease
Endocr. Rev., December 1, 2004; 25(6): 869 - 898.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
C. Rousseau, J. N. Nichol, F. Pettersson, M.-C. Couture, and W. H. Miller Jr.
ER{beta} Sensitizes Breast Cancer Cells to Retinoic Acid: Evidence of Transcriptional Crosstalk
Mol. Cancer Res., September 1, 2004; 2(9): 523 - 531.
[Abstract] [Full Text] [PDF]

Home page
 Vet PatholHome page
J. Martin de las Mulas, J. Ordas, M. Y. Millan, F. Chacon, M. De Lara, A. Espinosa de los Monteros, C. Reymundo, and A. Jover
Immunohistochemical Expression of Estrogen Receptor {beta} in Normal and Tumoral Canine Mammary Glands
Vet. Pathol., May 1, 2004; 41(3): 269 - 272.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
L Nakopoulou, A C Lazaris, E G Panayotopoulou, I Giannopoulou, N Givalos, S Markaki, and A Keramopoulos
The favourable prognostic value of oestrogen receptor {beta} immunohistochemical expression in breast cancer
J. Clin. Pathol., May 1, 2004; 57(5): 523 - 528.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Yu, A. Astrinidis, S. Howard, and E. P. Henske
Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways
Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L694 - L700.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Paruthiyil, H. Parmar, V. Kerekatte, G. R. Cunha, G. L. Firestone, and D. C. Leitman
Estrogen Receptor {beta} Inhibits Human Breast Cancer Cell Proliferation and Tumor Formation by Causing a G2 Cell Cycle Arrest
Cancer Res., January 1, 2004; 64(1): 423 - 428.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. A. W. Fuqua, R. Schiff, I. Parra, J. T. Moore, S. K. Mohsin, C. K. Osborne, G. M. Clark, and D. C. Allred
Estrogen Receptor {beta} Protein in Human Breast Cancer: Correlation with Clinical Tumor Parameters
Cancer Res., May 15, 2003; 63(10): 2434 - 2439.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. F. Verschraegen, W. Hu, Y. Du, J. Mendoza, J. Early, M. Deavers, R. S. Freedman, R. C. Bast Jr., A. P. Kudelka, J. J. Kavanagh, et al.
Establishment and Characterization of Cancer Cell Cultures and Xenografts Derived from Primary or Metastatic Mullerian Cancers
Clin. Cancer Res., February 1, 2003; 9(2): 845 - 852.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
K.-i. Matsuda, I. Ochiai, M. Nishi, and M. Kawata
Colocalization and Ligand-Dependent Discrete Distribution of the Estrogen Receptor (ER){alpha} and ER{beta}
Mol. Endocrinol., October 1, 2002; 16(10): 2215 - 2230.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Buteau-Lozano, M. Ancelin, B. Lardeux, J. Milanini, and M. Perrot-Applanat
Transcriptional Regulation of Vascular Endothelial Growth Factor by Estradiol and Tamoxifen in Breast Cancer Cells: A Complex Interplay between Estrogen Receptors {alpha} and {beta}
Cancer Res., September 1, 2002; 62(17): 4977 - 4984.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
V Speirs, G P Skliris, S E Burdall, and P J Carder
Distinct expression patterns of ER{alpha} and ER{beta} in normal human mammary gland
J. Clin. Pathol., May 1, 2002; 55(5): 371 - 374.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. V. Jensen, G. Cheng, C. Palmieri, S. Saji, S. Makela, S. Van Noorden, T. Wahlstrom, M. Warner, R. C. Coombes, and J.-A. Gustafsson
Estrogen receptors and proliferation markers in primary and recurrent breast cancer
PNAS, November 29, 2001; (2001) 211556298.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. G. Horvath, S. M. Henshall, C-S. Lee, D. R. Head, D. I. Quinn, S. Makela, W. Delprado, D. Golovsky, P. C. Brenner, G. O'Neill, et al.
Frequent Loss of Estrogen Receptor-{beta} Expression in Prostate Cancer
Cancer Res., July 1, 2001; 61(14): 5331 - 5335.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. Roger, M. E. Sahla, S. Mäkelä, J. A. Gustafsson, P. Baldet, and H. Rochefort
Decreased Expression of Estrogen Receptor {beta} Protein in Proliferative Preinvasive Mammary Tumors
Cancer Res., March 1, 2001; 61(6): 2537 - 2541.
[Abstract] [Full Text]

Home page
 Pharmacol. Rev.Home page
R. Clarke, F. Leonessa, J. N. Welch, and T. C. Skaar
Cellular and Molecular Pharmacology of Antiestrogen Action and Resistance
Pharmacol. Rev., March 1, 2001; 53(1): 25 - 72.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. M. Hall, C.-y. Chang, and D. P. McDonnell
Development of Peptide Antagonists That Target Estrogen Receptor {beta}-Coactivator Interactions
Mol. Endocrinol., December 1, 2000; 14(12): 2010 - 2023.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
V. Speirs, I. P. Adams, D. S. Walton, and S. L. Atkin
Identification of Wild-Type and Exon 5 Deletion Variants of Estrogen Receptor {beta} in Normal Human Mammary Gland
J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1601 - 1605.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
T. Otsuki, O. Yamada, J. Kurebayashi, T. Moriya, H. Sakaguchi, H. Kunisue, K. Yata, M. Uno, Y. Yawata, and A. Ueki
Estrogen Receptors in Human Myeloma Cells
Cancer Res., March 1, 2000; 60(5): 1434 - 1441.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Saji, E. V. Jensen, S. Nilsson, T. Rylander, M. Warner, and J.-A. Gustafsson
Estrogen receptors alpha and beta in the rodent mammary gland
PNAS, January 4, 2000; 97(1): 337 - 342.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
T. A. H. Jarvinen, M. Pelto-Huikko, K. Holli, and J. Isola
Estrogen Receptor {beta} Is Coexpressed with ER{alpha} and PR and Associated with Nodal Status, Grade, and Proliferation Rate in Breast Cancer
Am. J. Pathol., January 1, 2000; 156(1): 29 - 35.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
V. Speirs, C. Malone, D. S. Walton, M. J. Kerin, and S. L. Atkin
Increased Expression of Estrogen Receptor {{beta}} mRNA in Tamoxifen-resistant Breast Cancer Patients
Cancer Res., November 1, 1999; 59(21): 5421 - 5424.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. F. Couse and K. S. Korach
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
Endocr. Rev., June 1, 1999; 20(3): 358 - 417.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. V. Jensen, G. Cheng, C. Palmieri, S. Saji, S. Makela, S. Van Noorden, T. Wahlstrom, M. Warner, R. C. Coombes, and J.-A. Gustafsson
Estrogen receptors and proliferation markers in primary and recurrent breast cancer
PNAS, December 18, 2001; 98(26): 15197 - 15202.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.